关于因丁西马布诱导的非典型血溶性尿素性综合征的病例报告
Letha Huang1, Danielle Miller1, Fouad Hajjar2
1Department of Pediatric Pharmacy Advent Health for Children.
一份病例报告详细介绍了在神经母细胞瘤患者接受dinutuximab治疗后发生的非典型血清性尿素综合征 (aHUS). 这表明dinutuximab和aHUS之间存在潜在联系,需要进一步调查.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
背景情况:
- 神经母细胞瘤的治疗通常涉及免疫疗法,如dinutuximab.
- 非典型的血清性尿素综合征 (aHUS) 是一种罕见的病症,其特征是微血管病性血清性贫血,血栓细胞缩和功能衰竭.
更多相关视频
07:39Renal Subcapsular Transplantation of 2'-Deoxyguanosine-Treated Murine Embryonic Thymus in Nude Mice
Published on: July 19, 2019
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
相关概念视频
Drug Toxicity: Allergic Reactions
Hypersensitivity Reactions: Cytolytic Reactions
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
